Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Leaps by Bayer Leads USD 90 Million Series B Financing in Digital Health Company Ada Health
Leaps by Bayer, the impact investment arm of Bayer AG, today announces that it has […]
Portable ECG Device to be Further Rolled Out After Successful Pilot
A portable ECG monitoring device that detects heart irregularities is to be rolled out across […]
Novartis and Molecular Partners Announce Start of EMPATHY Clinical Trial for Ensovibep for the Treatment of COVID-19
Novartis and Molecular Partners announced today the start of the clinical trial EMPATHY, a Phase […]
Common Anti-inflammatory Drug Could Boost Cancer Immunotherapy
Widely-used anti-inflammatory drugs make tumours in mice more responsive to treatments that harness the power […]
Ibex Receives CE Mark for AI Breast Cancer Solution
Ibex Medical Analytics, an AI-powered cancer diagnostics firm, has received the CE mark for the […]
Moderna Announces TeenCOVE Study of COVID-19 Vaccine (mRNA-1273) in Adolescents Meets Primary Endpoint
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics
Akili Interactive (“Akili” or “Company”), maker of EndeavorRx™, the first and only prescription video game […]
Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings
Esco Lifesciences (“Esco”, the “Company”) announced today the close of an over-subscribed US$200 million Series A and Crossover […]
Flume Health Brings Total Raise to $10M With Fresh Equity Round; Looks to Transform Health Plan Administration and Drive Systemic Healthcare Change
Flume Health, a health plan administration platform for the modern fragmented healthcare ecosystem, today announced […]
Babylon Hires Former White House Health Official Darshak Sanghavi as New Chief Medical Officer
Babylon today announced the hiring of Darshak Sanghavi, MD as the company’s new Global Chief […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more